3,227 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

VSBC

VitaSpring Biomedical
US$15.000%2.7%US$3.1bn/aPE3319.2xn/an/a

300601

Shenzhen Kangtai Biological Products
CN¥19.5715.8%-33.1%CN¥21.9bCN¥22.31PE42.3xE38.9%2.0%

A128940

Hanmi Pharm
₩329,000.004.9%7.7%₩4.2t₩401,965.40PE22.6xE8.3%0.2%

XENE

Xenon Pharmaceuticals
US$40.735.4%14.4%US$3.1bUS$57.79PB3.7xE15.5%n/a

A302440

SK bioscienceLtd
₩53,800.00-4.1%-19.3%₩4.1t₩46,800.00PE150.7xE29.1%n/a

VITR

Vitrolife
SEK 234.60-8.0%69.3%SEK 31.8bSEK 271.67PS9xE105.9%0.4%

PFIZER

Pfizer
₹5,616.40-3.7%40.8%₹256.9b₹5,935.00PE42.2xE13.4%0.6%

BHC

Bausch Health Companies
US$8.320.7%2.6%US$3.1bUS$7.93PE-6.5xE118.9%n/a

RYTM

Rhythm Pharmaceuticals
US$49.63-3.3%112.3%US$3.0bUS$59.30PS29.8xE62.6%n/a

GXI

Gerresheimer
€79.10-19.0%-22.5%€2.7b€114.45PE22.7xE21.2%1.6%

688114

MGI Tech
CN¥50.9919.4%-31.9%CN¥21.0bCN¥60.48PS7.8xE142.1%0%

623

Jilin Aodong Pharmaceutical Group
CN¥17.3310.0%0.4%CN¥20.7bn/aPE22.2xE52.9%2.3%

APLLTD

Alembic Pharmaceuticals
₹1,242.854.0%60.8%₹244.3b₹1,092.17PE38.8xE19.1%0.9%

KDNY

Chinook Therapeutics
US$40.390.3%95.7%US$2.9bUS$40.09PS495.8xE22.6%n/a

A141080

LigaChem Biosciences
₩107,200.009.6%185.9%₩3.9t₩121,600.00PS51.2xE73.8%n/a

NATCOPHARM

NATCO Pharma
₹1,353.95-4.2%57.4%₹242.5b₹1,284.18PE14.8xE-8.2%0.4%

570

China Traditional Chinese Medicine Holdings
HK$4.412.3%20.2%HK$22.2bHK$4.81PE22xE-8.7%n/a

LAURUSLABS

Laurus Labs
₹445.15-4.2%11.7%₹240.0b₹399.47PE161.9xE50.8%0.2%

739

Apeloa PharmaceuticalLtd
CN¥17.249.3%-4.2%CN¥20.0bCN¥17.75PE18.5xE16.9%1.8%

MOR

MorphoSys
€67.650%n/a€2.5bn/aPS10.2xn/an/a

2773

Chengdu Kanghong Pharmaceutical Group
CN¥21.4410.0%35.0%CN¥19.7bn/aPE16.3xE12.0%1.8%

KYMR

Kymera Therapeutics
US$43.06-11.6%189.4%US$2.7bUS$55.88PS31xE-4.8%n/a

603858

Shandong Buchang Pharmaceuticals
CN¥17.916.1%-0.06%CN¥19.3bn/aPS1.6xn/a0.7%

300558

Betta Pharmaceuticals
CN¥45.9714.1%-19.7%CN¥19.2bCN¥50.10PE45.4xE28.2%0.4%
Page 11 of 135
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.